EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Annexin A11 and TDP-43: core players in neurodegeneration

Courtney L Smith, John L Robinson, Edward B Lee

Acta Neuropathologica · 07.07.2026 · 152 (1)

DOI: 10.1007/s00401-026-03043-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, online erschienen am 07.07.2026. Verfasst von Courtney L Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute On Aging, Perelman School of Medicine, Univ…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Annexins, Neurodegenerative Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Annexin A11 (ANXA11) is a Ca 2 ⁺-dependent phospholipid-binding protein that has recently emerged as a key player in neurodegeneration. Rare pathogenic ANXA11 variants were initially identified in cases of amyotrophic lateral sclerosis (ALS). Since then, ANXA11 has been linked to a broader spectrum of related neurodegenerative diseases. Two independent studies demonstrated that ANXA11 co-aggregates with TDP-43 in all cases of frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type C, with cryo-EM revealing heteromeric ANXA11–TDP-43 filaments. These discoveries support the direct pathological interaction between the two proteins as an important feature of FTLD-TDP type C. We also described secondary ANXA11 pathology in related neurodegenerative diseases, including limbic-predominant age-related TDP-43 encephalopathy (LATE), and more rarely in ALS and FTLD-TDP types A and B. ANXA11 and TDP-43 co-aggregates are also a feature of a FTLD-TDP associated with primary lateral sclerosis. These advances have renewed interest in ANXA11 as a major player in ALS/FTLD pathogenesis in both genetic and sporadic neurodegenerative diseases. In this review, we summarize ANXA11 pathology across genetic and sporadic cases, highlighting its heterogeneous overlap with TDP-43 pathology. We synthesize current knowledge of ANXA11’s physiological roles in phase separation, membrane repair, and RNA granule dynamics, integrating emerging evidence on how disruption of these processes may promote pathological aggregation and toxicity. Finally, we outline priorities for future research, with particular emphasis on elucidating ANXA11’s mechanistic connection to TDP-43.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsAnnexinsNeurodegenerative DiseasesHumansAnimalsTDP-43 Proteinopathies

Stichwörter der Autor:innen

ALSAnnexin A11FTLD-TDPNeurodegenerative diseaseTDP-43

Substanzen

DNA-Binding ProteinsTARDBP protein, humanAnnexins

Autor:innen und Institutionen

  • Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute On Aging, Perelman School of Medicine, University of Pennsylvania, 3rd Floor Maloney Building, 3400 Spruce Street…

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Smith, C. L., Robinson, J. L., & Lee, E. B. (2026). Annexin A11 and TDP-43: core players in neurodegeneration. Acta Neuropathologica, 152(1). https://doi.org/10.1007/s00401-026-03043-0

Vancouver

Smith CL, Robinson JL, Lee EB. Annexin A11 and TDP-43: core players in neurodegeneration. Acta Neuropathologica. 2026;152(1). doi:10.1007/s00401-026-03043-0

BibTeX
@article{Smith2026,
  author = {Smith, Courtney L and Robinson, John L and Lee, Edward B},
  title = {Annexin A11 and TDP-43: core players in neurodegeneration},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {152},
  number = {1},
  doi = {10.1007/s00401-026-03043-0}
}
Kostenlos starten →